"New French heart allocation system: comparison with Eurotransplant and United States allocation systems"

Recorded live on Tuesday, June 9th, 2020 • Hosted by the Thoracic and Critical Care Community of Practice (TCC COP)

"New French heart allocation system: comparison with Eurotransplant and United States allocation systems"

In this article:
"Graft allocation rules for heart transplantation are necessary because of the shortage of heart donors, resulting in high waitlist mortality. The Agence de la biomédecine is the agency in charge of the organ allocation system in France. Assessment of the 2004 urgency‐based allocation system identified challenging limitations. A new system based on a score ranking all candidates was implemented in January 2018. In the revised system, medical urgency is defined according to candidate characteristics rather than the treatment modalities, and an interplay between urgency, donor‐recipient matching, and geographic sharing was introduced. In this article, [the authors] describe in detail the new allocation system and compare these allocation rules to Eurotransplant and US allocation policies."

Howard Eisen, MD • Pennsylvania State University, Hershey, PA

Ryan Davies, MD, FACS • UT Southwestern Medical Center/Children's Medical Center, Dallas, TX

Watch Video

Educational Content Disclaimer: The content, information, opinions, and viewpoints contained in educational materials housed on and linked from the AST web site are those of the authors or contributors of such materials. While the AST and its committees take great care to screen the credentials of the contributors and make every attempt to review the contents, AST MAKES NO WARRANTY, EXPRESSED OR IMPLIED, as to the completeness or accuracy of the content contained in the educational materials or on this website. The reader of these materials uses these materials at his or her own risk, and AST shall not be responsible for any errors, omissions, or inaccuracies in these materials, whether arising through negligence, oversight, or otherwise. Reliance on any information appearing on this site is strictly at your own risk. Read the full disclaimer.